Robert O'Leary
Adult Reconstructive Orthopaedic Surgery · Albany, NYNPI 1275927766
Payments from drug & device makers
What this record shows
This record is dominated by education: $15,000 of the $23,157 with a category attached, or 64.8%. Smith+Nephew accounts for 64.8% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2021 at $8,681 and has fallen 89.9% since, to $877 in 2025.
Across 106 payments — averaging $218.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$15K
- Stryker$6K
- Zimmer Biomet$1K
- Johnson & Johnson$756
- Solventum Corporation$135
- Innovation Technologies Inc$41
- plus $21 from 1 others
What the payments were for
- Travel & lodging$9374%
- Food & beverage$7,22131%
- Education$15,00065%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 2 | $15,000 |
| Stryker | 82 | $6,200 |
| Zimmer Biomet | 9 | $1,004 |
| Johnson & Johnson | 10 | $756 |
| Solventum Corporation | 1 | $135 |
| Innovation Technologies Inc | 1 | $41 |
| Medical Device Business Services, Inc. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MAKO$2,736
- TRIATHLON$507
- Velys$482
- DALL-MILES$461
- AEQUALIS PERFORM$289
- Persona$289
- ACCOLADE$255
- Comprehensive Shoulder System$192
- 1788$162
- ATTUNE$136
- V.A.C. GRANUFOAM$135
- TRITANIUM$131
- INSIGNIA$121
- ORTHOMAP$121
How this compares
$23,157 in reported general payments places this provider in the 65th percentile of 85 adult reconstructive orthopaedic surgery providers in New York.
See all adult reconstructive orthopaedic surgery providers in New York →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 184 | $6,479 |
| Mupirocin | 195 | $1,444 |
| Amoxicillin | 227 | $571 |
| Diclofenac Sodium | 54 | $533 |
| Methylprednisolone | 65 | $472 |
| Meloxicam | 98 | $357 |
| Tramadol Hcl | 83 | $349 |
| Oxycodone Hcl | 51 | $272 |
| Cephalexin | 43 | $254 |
| Clindamycin Hcl | 50 | $129 |
| Cyclobenzaprine Hcl | 15 | $71 |
| Ondansetron Hcl | 11 | $57 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Albany
- Seth JerabekNew York$7.1M
- Jose RodriguezNew York$3.4M
- Friedrich BoettnerNew York$2.9M
- Jonathan VigdorchikNew York$2.3M
- William LongNew York$1.5M
- Peter SculcoNew York$1.5M
- Roshan ShahNew York$1.3M
- Herbert CooperNew York$1.3M
- Matthew AustinNew York$986K
- Patrick MeereNew York$191K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.